News & Events about Syneos Health Inc.
Globe Newswire
2 months ago
MORRISVILLE, N.C., April 04, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced Jeanine OKane as President of Syneos Health Communications a portfolio of agencies spanning advertising, public relations, patient ...
Globe Newswire
2 months ago
Program Drives Digital and Omnichannel Engagement for Medical Science Liaison TeamsMedical ConferencesMORRISVILLE, N.C., March 27, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today announced the launch of Medical Affairs...
Ticker Report
3 months ago
Syneos Health (NASDAQ:SYNH Get Rating) had its target price increased by Robert W. Baird from $42.00 to $51.00 in a research report sent to investors on Friday morning, The Fly reports. Several other analysts also recently commented on the stock. JPMorgan Chase Co. downgraded shares of...
Globe Newswire
3 months ago
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and full year 2022 financial results on Thursday, February 16, 2023, prior to its earnings call at 8:00 a.m. ET. To ...
Globe Newswire
3 months ago
MORRISVILLE, N.C., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced a strategic partnership with Equicare to use proXimity, an innovative cloud-based software platform that accelerates the transfer of ...